Clinical Trial Update: LIPT - Liraglutide in Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update for liraglutide in polycystic ovary syndrome has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Polycystic Ovary Syndrome

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Jens Faber | Conditions: Polycystic Ovary Syndrome, Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-02-28